title: Inhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activity.
abstract: A controlled mutational study was used to determine the site and mechanism of the antiviral action of ribozymes that inhibit Sindbis virus replication. A hairpin ribozyme targeting G575 of the Sindbis virus genomic RNA was designed and cloned into a minimized alphavirus amplicon vector. Cells that were stably transfected with this construct expressed low levels of a constitutive transcript containing the ribozyme plus recognition sequences for Sindbis RNA replicase. Upon infection, the ribozyme transcript was amplified to high levels by the viral replicase, resulting in decreased viral production from infected ribozyme-expressing cells. Mutations were then introduced into the viral RNA target sequence to interfere with ribozyme binding, and compensatory changes were generated in the ribozyme recognition sequence. Single mutations in the virus or ribozyme decreased the efficacy of the ribozyme's inhibition of viral replication, and compensatory mutations restored it. To confirm that ribozyme-catalyzed RNA cleavage was actually needed for inhibition, we performed tests with a cell line expressing an inactivated ribozyme and with a virus containing a single nucleotide target mutation that allowed the ribozyme to bind but blocked cleavage at the recognition site. The results show that most of the antiviral activity of ribozymes is due to ribozyme-catalyzed cleavage at the targeted RNA sequence, but some additional inhibition seems to occur through an antisense mechanism.
authors.affiliation: Department of Microbiology and Molecular Genetics, The University of Vermont, 95 Carrigan Dr., 220 Stafford Hall, Burlington, VT 05405, USA.
authors.forename: Zhenxi
authors.initials: Z
authors.lastname: Zhang
authors.forename: John M
authors.initials: JM
authors.lastname: Burke
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001483:Base Sequence; D002478:Cells, Cultured; D006224:Cricetinae; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D017354:Point Mutation; D016337:RNA, Catalytic / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*; D012367:RNA, Viral / Q000378:metabolism; D012324:RNA-Dependent RNA Polymerase / Q000235:genetics / Q000378:metabolism; D012845:Sindbis Virus / Q000187:drug effects* / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D016337:RNA, Catalytic; D012367:RNA, Viral; D012324:RNA-Dependent RNA Polymerase
references.citation: Biochemistry. 1999 Dec 7;38(49):16035-9
references.pmid: 10587425
references.citation: J Virol. 1999 Jul;73(7):5381-7
references.pmid: 10364285
references.citation: J Mol Biol. 2000 May 5;298(3):539-55
references.pmid: 10772868
references.citation: RNA. 2000 Apr;6(4):628-37
references.pmid: 10786853
references.citation: Nature. 2001 Apr 12;410(6830):780-6
references.pmid: 11298439
references.citation: J Mol Biol. 2001 Jun 15;309(4):893-902
references.pmid: 11399066
references.citation: EMBO J. 2001 Nov 15;20(22):6434-42
references.pmid: 11707414
references.citation: RNA. 2001 Nov;7(11):1638-51
references.pmid: 11720292
references.citation: Expert Opin Biol Ther. 2001 Mar;1(2):177-91
references.pmid: 11727528
references.citation: J Mol Med (Berl). 2001 Dec;79(12):695-706
references.pmid: 11862313
references.citation: J Biol Chem. 2002 Jul 19;277(29):25957-62
references.pmid: 12006558
references.citation: Am J Pharmacogenomics. 2003;3(2):131-44
references.pmid: 12749730
references.citation: Anticancer Res. 2003 May-Jun;23(3A):1997-2005
references.pmid: 12894572
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10802-6
references.pmid: 1438280
references.citation: J Virol. 1993 Nov;67(11):6439-46
references.pmid: 8411346
references.citation: Virology. 1994 Jan;198(1):381-4
references.pmid: 8259675
references.citation: J Biol Chem. 1994 Apr 15;269(15):11361-6
references.pmid: 8157667
references.citation: Microbiol Rev. 1994 Sep;58(3):491-562
references.pmid: 7968923
references.citation: Adv Exp Med Biol. 1995;380:399-404
references.pmid: 8830515
references.citation: Virology. 1996 Jun 15;220(2):361-6
references.pmid: 8661387
references.citation: Virology. 1996 Aug 15;222(2):464-9
references.pmid: 8806532
references.citation: Methods Mol Biol. 1997;74:161-9
references.pmid: 9204431
references.citation: RNA. 1997 Sep;3(9):961-73
references.pmid: 9292496
references.citation: Annu Rev Microbiol. 1997;51:565-92
references.pmid: 9343360
references.citation: Mol Cell. 1998 May;1(6):873-81
references.pmid: 9660970
references.citation: Nucleic Acids Res. 1998 Aug 1;26(15):3494-504
references.pmid: 9671810
references.citation: J Biol Chem. 1998 Sep 4;273(36):23524-33
references.pmid: 9722591
references.citation: Biochemistry. 1998 Dec 15;37(50):17629-36
references.pmid: 9860879
references.citation: Antiviral Res. 1999 May;42(1):47-57
references.pmid: 10333142
references.citation: Nat Struct Biol. 1999 Jun;6(6):544-9
references.pmid: 10360357
references.citation: Hepatology. 2000 Mar;31(3):769-76
references.pmid: 10706571